Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cells
Sisi Chen, Gaoying Chen, Fang Xu, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

CAR T therapy beyond cancer: the evolution of a living drug
Daniel Baker, Zoltàn Arany, Joseph A. Baur, et al.
Nature (2023) Vol. 619, Iss. 7971, pp. 707-715
Closed Access | Times Cited: 233
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 67
Engineering the IL‐4/IL‐13 axis for targeted immune modulation
Zachary J. Bernstein, Anjali Shenoy, Amy Chen, et al.
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 29-57
Open Access | Times Cited: 43
A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice
Gang Jin, Yanyan Liu, Lixia Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 6, pp. 1059-1072
Closed Access | Times Cited: 16
New cell sources for CAR-based immunotherapy
Marzieh Mazinani, Fatemeh Rahbarizadeh
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 25
From mechanism to therapy: the journey of CD24 in cancer
Kai Zhao, Caifeng Wu, Xiangjun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Sex hormones and allergies: exploring the gender differences in immune responses
Jesús Alberto Gutiérrez-Brito, José Álvaro Lomelí-Nieto, José Francisco Muñoz‐Valle, et al.
Frontiers in Allergy (2025) Vol. 5
Open Access
Iron Drives Eosinophil Differentiation in Allergic Airway Inflammation Through Mitochondrial Metabolic Adaptation
Fei Li, Hao‐Yu Tang, Yuejue Wang, et al.
Advanced Healthcare Materials (2025)
Closed Access
Precise CAR-T-cell Therapy Targeting Non-Cancerous Diseases: Advances in Precision Medicine and Bioengineering
Chaojie Zhu, Fangzhou Wang, Zesheng Cheng, et al.
Precision medicine and engineering. (2025), pp. 100024-100024
Open Access
The road ahead for chimeric antigen receptor T cells
Carli M. Stewart, Elizabeth L. Siegler, Saad S. Kenderian
The Journal of Immunology (2025)
Closed Access
Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer
Lvying Wu, Lingfeng Zhu, Jin Chen
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Clinical Reviews in Allergy & Immunology (2024) Vol. 66, Iss. 3, pp. 328-362
Closed Access | Times Cited: 3
Protective effects of Angelica decursiva Franchet & Savatier on allergic responses through enhancement of Nrf2 and suppression of NF-kB/MMP-9 in ovalbumin-exposed mice
Se‐Jin Lee, A Yeong Lee, So‐Won Pak, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116863-116863
Open Access | Times Cited: 8
CAR T treatment beyond cancer: Hope for immunomodulatory therapy of non-cancerous diseases
Zhibo Yang, Yingfeng Liu, Zhao Hai
Life Sciences (2024) Vol. 344, pp. 122556-122556
Open Access | Times Cited: 1
Immunologic aspects of asthma: from molecular mechanisms to disease pathophysiology and clinical translation
Cong Xie, Jingyan Yang, Aman Gul, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
Congli Wu
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Interfacial-engineered living drugs with “ON/OFF” switching for oral delivery
Pingping Feng, Xuefei Bai, Xiaofei Ma, et al.
Nanoscale (2024) Vol. 16, Iss. 28, pp. 13399-13406
Closed Access
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma
Junho Kim, Dae Seong Kim, Hae‐Sim Park, et al.
Clinical Immunology (2023) Vol. 255, pp. 109755-109755
Closed Access | Times Cited: 1
Development and characterization of anti-IL-5 monoclonal antibody Fab fragment for blocking IL-5/IL-5Rα binding
Shijie Li, Shijie Wang, Eric Fordjour, et al.
International Immunopharmacology (2023) Vol. 124, pp. 111032-111032
Closed Access | Times Cited: 1
Page 1

Scroll to top